Found: 35
Select item for more details and to access through your institution.
(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 85, doi. 10.3390/ph14020085
- By:
- Publication type:
- Article
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 6, p. 113, doi. 10.3390/ph13060113
- By:
- Publication type:
- Article
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7026, doi. 10.3390/ijms21197026
- By:
- Publication type:
- Article
Antiproliferative Activity Evaluation of a Series of N-1,3-Benzothiazol-2-ylbenzamides as Novel Apoptosis Inducers.
- Published in:
- Journal of Chemistry, 2016, p. 1, doi. 10.1155/2016/4267564
- By:
- Publication type:
- Article
Structural requisites of 2-(p-chlorophenoxy) propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.
- Published in:
- British Journal of Pharmacology, 2003, v. 139, n. 7, p. 1255, doi. 10.1038/sj.bjp.0705364
- By:
- Publication type:
- Article
Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K[subSTP] channel.
- Published in:
- British Journal of Pharmacology, 2003, v. 139, n. 2, p. 255, doi. 10.1038/sj.bjp.0705233
- By:
- Publication type:
- Article
A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects.
- Published in:
- ChemMedChem, 2021, v. 16, n. 3, p. 484, doi. 10.1002/cmdc.202000564
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine‐2,5‐dione Hybrids as Potential Antitumor Agents.
- Published in:
- ChemMedChem, 2020, v. 15, n. 19, p. 1813, doi. 10.1002/cmdc.202000458
- By:
- Publication type:
- Article
N-(2-(Benzylamino)ethyl)-4-(naphthalene-1-sulfonamido)benzamide.
- Published in:
- Molbank, 2024, v. 2024, n. 3, p. M1856, doi. 10.3390/M1856
- By:
- Publication type:
- Article
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.
- Published in:
- Scientific Reports, 2016, p. 34792, doi. 10.1038/srep34792
- By:
- Publication type:
- Article
Screening of saponins and sapogenins from Medicago species as potential PPARγ agonists and X-ray structure of the complex PPARγ/caulophyllogenin.
- Published in:
- Scientific Reports, 2016, p. 27658, doi. 10.1038/srep27658
- By:
- Publication type:
- Article
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 694, doi. 10.3390/biom13040694
- By:
- Publication type:
- Article
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 1, p. 111, doi. 10.3390/biom11010111
- By:
- Publication type:
- Article
Resveratrol and Its Metabolites Bind to PPARs.
- Published in:
- ChemBioChem, 2014, v. 15, n. 8, p. 1154, doi. 10.1002/cbic.201300754
- By:
- Publication type:
- Article
Synthesis and in vitro cytotoxicity of benzoxazole‐based PPARα/γ antagonists in colorectal cancer cell lines.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 9, p. 1, doi. 10.1002/ardp.202400086
- By:
- Publication type:
- Article
Identification of Novel Matrix Metalloproteinase Inhibitors by Screening of Phenol Fragments Library.
- Published in:
- Archiv der Pharmazie, 2011, v. 344, n. 9, p. 557, doi. 10.1002/ardp.201000350
- By:
- Publication type:
- Article
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding.
- Published in:
- Molecules, 2022, v. 27, n. 15, p. 4735, doi. 10.3390/molecules27154735
- By:
- Publication type:
- Article
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).
- Published in:
- Molecules, 2022, v. 27, n. 3, p. 958, doi. 10.3390/molecules27030958
- By:
- Publication type:
- Article
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents.
- Published in:
- Applied Sciences (2076-3417), 2020, v. 10, n. 12, p. 4118, doi. 10.3390/app10124118
- By:
- Publication type:
- Article
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's Disease.
- Published in:
- Antioxidants, 2022, v. 11, n. 9, p. 1631, doi. 10.3390/antiox11091631
- By:
- Publication type:
- Article
HDAC4 Inhibitors with Cyclic Linker and Non‐hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in vitro Cytotoxicity evaluation.
- Published in:
- ChemistrySelect, 2021, v. 6, n. 26, p. 6748, doi. 10.1002/slct.202102061
- By:
- Publication type:
- Article
Different behavior toward racemization in basic media from chiral analogs of clofibric acid, the active metabolite of the antilipidemic drug clofibrate.
- Published in:
- Chirality, 2000, v. 12, n. 10, p. 697, doi. 10.1002/1520-636X(2000)12:10<697::AID-CHIR1>3.0.CO;2-L
- By:
- Publication type:
- Article
Facile entry to (−)-( R)- and (+)-( S)-mexiletine.
- Published in:
- Chirality, 2000, v. 12, n. 3, p. 103, doi. 10.1002/(SICI)1520-636X(2000)12:3<103::AID-CHIR1>3.0.CO;2-X
- By:
- Publication type:
- Article
Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor α (rPPARα) activation and peroxisomal fatty acid β-oxidation.
- Published in:
- Chirality, 1997, v. 9, n. 1, p. 37, doi. 10.1002/(SICI)1520-636X(1997)9:1<37::AID-CHIR8>3.0.CO;2-D
- By:
- Publication type:
- Article
Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.
- Published in:
- Molecules, 2018, v. 23, n. 9, p. 2182, doi. 10.3390/molecules23092182
- By:
- Publication type:
- Article
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41765-2
- By:
- Publication type:
- Article
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study.
- Published in:
- International Journal of Molecular Medicine, 2018, v. 42, n. 1, p. 651, doi. 10.3892/ijmm.2018.3641
- By:
- Publication type:
- Article
Structure-Based Design of Microsomal Prostaglandin E<sub>2</sub> Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme.
- Published in:
- ChemMedChem, 2016, v. 11, n. 6, p. 612, doi. 10.1002/cmdc.201500598
- By:
- Publication type:
- Article
On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator-Activated Receptors and Skeletal Muscles.
- Published in:
- ChemMedChem, 2015, v. 10, n. 3, p. 555, doi. 10.1002/cmdc.201402462
- By:
- Publication type:
- Article
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption.
- Published in:
- ChemMedChem, 2011, v. 6, n. 7, p. 1258, doi. 10.1002/cmdc.201000540
- By:
- Publication type:
- Article
Cover Picture: Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption (ChemMedChem 7/2011).
- Published in:
- ChemMedChem, 2011, v. 6, n. 7, p. 1133, doi. 10.1002/cmdc.201190027
- By:
- Publication type:
- Article
Synthesis, SAR, and Biological Evaluation of α-Sulfonylphosphonic Acids as Selective Matrix Metalloproteinase Inhibitors.
- Published in:
- ChemMedChem, 2009, v. 4, n. 3, p. 352, doi. 10.1002/cmdc.200800324
- By:
- Publication type:
- Article
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARα and PPARγ Agonist Activity.
- Published in:
- ChemMedChem, 2007, v. 2, n. 5, p. 641, doi. 10.1002/cmdc.200600307
- By:
- Publication type:
- Article
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases.
- Published in:
- Foods, 2021, v. 10, n. 1, p. 29, doi. 10.3390/foods10010029
- By:
- Publication type:
- Article
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases.
- Published in:
- ARKIVOC: Online Journal of Organic Chemistry, 2009, p. 265
- By:
- Publication type:
- Article